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Introduction
Faithful chromosome segregation requires that sister chroma-
tids attach their kinetochores to opposite poles of the mitotic 
spindle. To prevent genome instability, mitotic exit is delayed 
by the spindle assembly checkpoint (SAC; Rieder et al., 1994; 
Rieder and Salmon, 1998; Alexandru et al., 1999; Musacchio 
and Salmon, 2007; Musacchio, 2011; Foley and Kapoor, 2013) 
until all kinetochores are correctly bioriented. The core SAC 
machinery undergoes enzymatic and/or conformational acti-
vation at kinetochores to form the mitotic checkpoint complex 
(Musacchio and Salmon, 2007; Lara-Gonzalez et al., 2012), 
which prevents mitotic exit by inhibiting the anaphase-promot-
ing complex/cyclosome (APC/C) and E3 ubiquitin ligase.
An essential regulator of the checkpoint machinery is the 
mitotic kinase Mps1 (Weiss and Winey, 1996; Hardwick et al., 
1996; Abrieu et al., 2001; Stucke et al., 2002; Jelluma et al., 
2008a; Santaguida et al., 2010). Mps1 activity directs check-
point proteins to unattached kinetochores (Lan and Cleveland, 
2010), allows Mad2 conformational activation (Hewitt et al., 
2010), and stabilizes the cytoplasmic APC/C inhibitory com-
plexes (Maciejowski et al., 2010). It thereby prevents the cell 
cycle from prematurely advancing from metaphase to anaphase 
before attachment of every chromosome to spindle microtu-
bules (Abrieu et al., 2001; Stucke et al., 2002). In the absence 
of Mps1 activity, the SAC is constitutively inactivated, and cells 
therefore become rapidly aneuploid and subsequently die (Kops 
et al., 2005). Mps1 activity rises during mitosis (Stucke et al., 
2002), when it becomes localized to kinetochores (Howell et al., 
2004) and is autoactivated by cross-phosphorylation of its acti-
vation loop (Kang et al., 2007; Jelluma et al., 2008b) as a dimer 
(Hewitt et al., 2010). Although the essential function of Mps1 
to establish the SAC has been reported in many model systems 
(Hardwick et al., 1996; Weiss and Winey, 1996; He et al., 1998; 
Abrieu et al., 2001), it is not understood how Mps1 is targeted 
to kinetochores and how the cell ensures that the right amount 
of Mps1 activity is present at kinetochores during mitosis.
Here, we functionally characterize ARH GEF17, an es-
sential mitotic gene, identified in the MitoCheck genome-wide 
RNAi screen (Neumann et al., 2010). ARH GEF17 was origi-
nally identified as a guanine nucleotide exchange factor (GEF) 
of the Rho GTPase family, with a function in regulation of the 
interphase cytoskeleton (Rümenapp et al., 2002). ARH GEF17 
is a 2,063-aa-long protein, and only its 187-aa GEF domain is 
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functionally annotated. A mitotic function of ARH GEF17 had 
not been reported before MitoCheck. Here, we demonstrate that 
ARH GEF17 is essential for the SAC and for targeting Mps1 
to mitotic kinetochores, that the ARH GEF17–Mps1 interaction 
is regulated by Mps1 kinase activity, and that ARH GEF17 is 
a substrate of Mps1 kinase. We propose a model in which the 
autoregulated ARH GEF17–Mps1 targeting complex acts as 
a timer to ensure the correct level of Mps1 activity for SAC 
function at kinetochores.
Results
ARH GEF17 is a human mitotic gene
ARH GEF17 was discovered as a mitotic hit in the MitoCheck 
RNAi screen because of its polylobed nuclear phenotype (Neu-
mann et al., 2010). Because polylobed nuclei can arise owing to 
several mitotic defects that were not captured with the time res-
olution of the genome-wide screen, we assayed this phenotype 
in more detail with high-resolution confocal time-lapse imag-
ing of chromosomes (H2B-mCherry) and the nuclear envelope 
(laminA-mEGFP). Dividing HeLa cells depleted for ARH 
GEF17 showed dramatically accelerated mitosis and proceeded 
directly from prometaphase to anaphase, without detectable 
chromosome congression and biorientation in metaphase, so 
that anaphase onset occurred on average 9.1 (± 4.8) min after 
nuclear envelope breakdown, compared with 25.4 (± 3.0) min 
in control cells (Fig. 1, A and B). Consequently, chromosome 
segregation was highly abnormal, leading to prominent chro-
mosome bridges, explaining the formation of polylobed nuclei 
after segregation (Fig. 1 A, arrow). The dramatic mitotic accel-
eration and complete skipping of metaphase suggest that the 
SAC is severely compromised in the absence of ARH GEF17.
To confirm ARH GEF17 as the siRNA target gene 
responsible for the phenotype, we next performed phenotypic 
rescue with an RNAi-resistant ARH GEF17 transgene, using 
the mouse orthologue of ARH GEF17 in a bacterial artificial 
chromosome (BAC; mARH GEF17; Poser et al., 2008), stably 
expressed in a HeLa cell line with fluorescently labeled 
chromosomes (H2B-mCherry). The on-target knockdown was 
efficient, as endogenous hARH GEF17 protein was reduced by 
>80% after knockdown with four independent human-specific 
siRNAs in both parental and mARH GEF17-expressing HeLa 
cells (Fig. S1 A). Time-lapse imaging and quantitation of mitotic 
phenotypes in cell populations by automatic classification of 
chromosome morphologies using CellCognition (Held et al., 
2010; Walter et al., 2010; http ://www .cellcognition .org, see 
Materials and methods) confirmed a significant increase of 
Figure 1. ARH GEF17 is required for SAC. 
(A and B) Knockdown (KD) of hARH GEF17 
in HeLa Kyoto cells stably expressing H2B-
mCherry and EGFP-laminA. (A) Time series 
of cells treated with si(Scrambled) (Sc) or 
si(hARH GEF17) (KD). Arrowhead marks a 
chromosome bridge. (B) Comparison of early 
mitotic duration (prometaphase + metaphase) 
from >22 mitosis/three independent exper-
iments. (C and D) Validation of siRNA tar-
geting of hARH GEF17 by phenotypic rescue 
through LAP-mARH GEF17-BAC. (C) Nuclei 
(H2B-mCherry) 48 h after siRNA transfection 
with or without LAP-mARH GEF17-BAC rescue. 
(D) Comparison of polylobed nuclei popula-
tions (normalized to Scrambled in each con-
dition) from >6,000 cells/three independent 
experiments. siRNA number indicated (see 
Materials and methods). (E and F) SAC activ-
ity of ARH GEF17. (E) Nuclei (H2B-mCherry) 
treated with 0.33 µM nocodazole 48 h after 
siRNA transfection with or without LAP-mARH 
GEF17-BAC rescue. (F) Comparison of cell 
populations in prometaphase of >4,500 cells/
three independent experiments. siRNA number 
indicated. (G) Quantitative expression analy-
sis of checkpoint proteins at kinetochores in 
prometaphase. (left) Localization of Mad2, 
BubR1, or Bub1 after Scrambled or hARH 
GEF17-KD. (inset) High magnification of kine-
tochores. Black lines outline segmented chro-
mosomes. (right) Comparison of mean intensity 
ratio between checkpoint proteins and CENP-A 
at >1,300 individual sister kinetochores/three 
independent experiments. Bar graphs show 
mean ± SD; boxes show median, 25–75%; 
whiskers show 1.5× interquartile range. 
Bars: (A and G) 5 µm; (G, inset) 0.5 µm; (C and 
E) 10 µm. **, P < 0.01 by two-tailed unpaired 
Student’s t test, compared with si(Scrambled) 
(B and G) or without a rescue construct (D).
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polylobed nuclei after ARH GEF17 knockdown with all siRNAs, 
indicative of failed chromosome segregation (Fig.  1, C and 
D). For all siRNAs, expression of the siRNA-resistant mARH 
GEF17 significantly reduced the abundance of polylobed nuclei 
(Fig. 1 D). To confirm that this phenotypic rescue was indeed 
caused by mARH GEF17 and not other sequences present on the 
BAC rescue construct, we performed double knockdown of both 
human and mouse ARH GEF17 by two siRNAs, which restored 
the polylobed phenotype, demonstrating that the rescue was 
specific to mARH GEF17 (Fig. S1 B). ARH GEF17 is therefore 
a bona fide human mitotic gene.
ARH GEF17 is required for the SAC
The mitotic acceleration phenotype of ARH GEF17 knockdown 
suggests that it is required for the SAC. We therefore tested 
whether ARH GEF17 depletion would abolish the checkpoint- 
dependent cell cycle arrest induced by the microtubule- 
depolymerizing drug nocodazole. Whereas a large fraction of 
control cells treated with nocodazole arrested in prometaphase, 
only very few cells depleted of ARH GEF17 were found in 
prometaphase after drug treatment (Fig.  1  E). This checkpoint 
override was rescued by the siRNA-resistant mARH GEF17 
transgene for all four siRNAs targeting hARH GEF17 (Fig. 1 F). 
Because overall protein expression of hMad2 was not affected 
by ARH GEF17 knockdown (Fig. S2 A) and a mouse Mad2 or-
thologue construct could not rescue the ARH GEF17 knockdown 
phenotype (and vice versa; Fig. S2, B and C), we excluded the 
possibility of off-target gene silencing of hMad2 by hARH 
GEF17 siRNAs, previously reported for other gene targets (Hüb-
ner et al., 2010; Westhorpe et al., 2010; Sigoillot et al., 2012). The 
expression levels of other checkpoint proteins such as BubR1 and 
Bub1 were also not affected by ARH GEF17 knockdown (Fig. S2 
D). Thus, ARH GEF17 is specifically required for the SAC.
ARH GEF17 localizes to kinetochores and 
is required for targeting of checkpoint and 
outer kinetochore proteins
Given that the SAC operates at kinetochores, we next in-
vestigated the subcellular distribution of endogenous ARH 
GEF17 during mitosis using immunofluorescence with anti- 
ARH GEF17 antibodies. In dividing HeLa cells, endogenous 
ARH GEF17 localized to the mitotic spindle, the cytoplasm, 
and the kinetochores (Fig. S2 E). Since even the best available 
antibody showed relatively weak kinetochore labeling over the 
cytoplasmic background, we confirmed the kinetochore lo-
calization on chromosome spreads from cells arrested in pro-
metaphase with nocodazole, where endogenous ARH GEF17 
prominently localized to the centromere/kinetochore region 
(Fig. S2 F), consistent with a function in the SAC.
To understand how ARH GEF17 is required for SAC 
function, we tested whether its depletion affects the kineto-
chore targeting of checkpoint proteins, which has been shown 
Figure 2. ARH GEF17 fragment restores SAC func-
tion independently of catalytic activity for Rho GEF 
of ARH GEF17. (A) Schematic depiction of hARH 
GEF17 variants used in phenotypic rescue assays: 
FL: hARH GEF17 (1–2,063)-mEGFP; FL Y1216A: 
hARH GEF17 (1–2,063)-Y1216A-mEGFP; ΔN: hARH 
GEF17 (667–2,063)-mEGFP; ΔNC: hARH GEF17 
(667–1,306)-mEGFP; ΔNC Y1216A: hARH GEF17 
(667–1,306)-Y1216A-mEGFP; ΔC-siRa: hARH 
GEF17 (1–582)-mEGFP; ΔC-siRb: hARH GEF17 
(109–664)-mEGFP; ΔN1: mEGFP-hARH GEF17 
(1,304–2,063)-mEGFP; and ΔN2: hARH GEF17 
(1,304–2,063)-mEGFP. Gray boxes indicate GEF ac-
tivity domain (Dbl-homologous domain); Y1216A indi-
cates the inactivating mutation in the GEF domain; red 
lines indicate sites for mutations for siRNA resistance. 
(B) Immunoblot analysis of hARH GEF17 fragments 
fused to GFP (detected with anti-GFP). GAP DH, load-
ing control. (C and D) Rescue of hARH GEF17 knock-
down-induced polylobulation (C) or SAC defect (D). 
Comparison of polylobed (C; normalized to Scram-
bled) or prometaphase population (D; nocodazole 
treated) rescued with hARH GEF17 fragments (ΔN-
mEGFP, ΔNC-mEGFP, and ΔNC Y1216A-mEGFP) of 
>11,500 (C) or >6,300 (D) cells/three independent 
experiments. (E) Phenotypic analysis of cytokinesis 
defects (binucleation) of a catalytically inactive mu-
tant of full-length ARH GEF17 (FL Y1216A) during 
mitosis. (left) H2B-mCherry, wild-type full-length (FL-
mEGFP), catalytically inactive (FL Y1216A-mEGFP), 
or cells 24 h after CT04 treatment (0.25 mg/ml; FL 
+ CT04). (right) Comparison of binuclear population 
of >3,000 cells/three independent experiments. Bar 
graphs show mean ± SD. **, P < 0.01 by two-tailed 
unpaired Student’s t test, compared with no rescue 
construct (C), si(Scrambled) without a rescue construct 
(D), or FL-mEGFP (E). Cells automatically segmented/
analyzed by CellCognition. Bars, 10 µm.
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to compromise SAC function in several cases (Hewitt et al., 
2010; Jelluma et al., 2010; Maciejowski et al., 2010; San-
taguida et al., 2010). We therefore systematically analyzed 
the localization of proteins representative of the different 
kinetochore layers and checkpoint complexes by ratiometric 
immunofluorescence in prometaphase cells. ARH GEF17 de-
pletion led to a strong and significant reduction of kinetochore 
localization of checkpoint and outer kinetochore proteins, in-
cluding Mad2, BubR1, and Bub1 (Fig.  1  G), although their 
overall expression level was not affected (Fig. S2, A and D). 
The kinetochore localization of linker and inner kinetochore 
proteins was affected to a lesser extent or not at all (Fig. S2 
G). The strong targeting defect of all tested outer kinetochore 
and checkpoint proteins explains the absence of SAC activity 
after ARH GEF17 depletion.
The mitotic function of ARH GEF17 resides 
in a central domain and is independent of 
its Rho GEF activity
ARH GEF17’s only functionally annotated domain has been 
shown to function as a GTP exchange factor for the small GTPase 
Rho in interphase (Rümenapp et al., 2002). To determine which 
part of hARH GEF17 is required for the SAC, we truncated 
hARH GEF17, introduced silent siRNA resistance mutations 
(Fig. 2, A and B), and tested which of the proteins could rescue 
the mitotic phenotype of ARH GEF17 knockdown. In contrast 
to hARH GEF17 containing only either the N or C  terminus 
alone, both fragments containing the central (aa 667–1,306) 
domain (ΔN-mEGFP and ΔNC-mEGFP) were able to fully res-
cue the hARH GEF17 depletion in HeLa cells and reduced the 
abundance of polylobed nuclei to levels indistinguishable from 
Figure 3. ARH GEF17 knockdown phenocopies Mps1 inhibition. Mitosis and nuclear morphology automatically extracted after si(Scrambled), si(hARH 
GEF17) knockdown (KD), reversine, and hesperadin treatment conditions. Colors indicate H2B-mCherry morphology classes. (A) Examples of single mitotic 
events. Δt is 9 min. Bar, 10 µm. (B) Automated extraction of mitotic events and morphology classes. (C) Comparison of early mitotic duration (prometa + 
metaphase) of >21 mitotic events (n indicated for each condition)/three independent experiments. Early mitotic duration in hesperadin-treated conditions 
was underestimated because of fixed analysis time (3 h). Boxes show median, 25–75%; whiskers show 1.5× interquartile range. **, P < 0.01 by two-tailed 
unpaired Student’s t test compared with si(Scrambled).
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controls (Figs. 2 C and S2 H). The central domain also restored 
the SAC-dependent nocodazole-induced prometaphase arrest to 
levels similar to those of controls (Fig. 2 D). Thus, the central 
domain of hARH GEF17 is sufficient for SAC activity.
Since this central domain contains the well-conserved Dbl 
homology domain essential for the GEF activity of ARH GEF17, 
we introduced a point mutation in the catalytic site (ΔNC Y1216A-
mEGFP; Zheng, 2001; Rümenapp et al., 2002; Fig. 2 A). Over-
expression of full-length hARH GEF17 (FL-mEGFP) carrying the 
point mutation Y1216A (FL Y1216A-mEGFP) inhibited cytoki-
nesis, leading to an overabundance of binucleated cells, similar 
to the Rho inhibitor CT04, suggesting that the Y1216A mutation 
produced an enzymatically dead GEF that can inhibit Rho’s cytoki-
nesis activity (Fig. 2 E). In contrast, the GEF-dead central domain 
construct ΔNC Y1216A fully rescued the polylobed and noco-
dazole early-mitotic-arrest phenotypes caused by ARH GEF17 
depletion (Fig. 2, C and D). The mitotic SAC function of hARH 
GEF17 is therefore independent of its Rho GEF activity.
Figure 4. ARH GEF17 and Mps1 interact during mitosis. (A) Coimmunoprecipitation of ARH GEF17 with Mps1: LAP-tagged Mps1 (LAP-Mps1) and mCher-
ry-tagged ARH GEF17 (ARH GEF17-mCherry) were immunoprecipitated using GFP-binding protein coupled to agarose beads. Input, supernatants (Un-
bound), and immunoprecipitates (Bound) were analyzed by Western Blot (anti-GFP and anti-mCherry). (B and C) FCCS of Mps1 and ARH GEF17. 
Exemplary cells (B; yellow crosses mark position for FCCS measurement) and normalized cross-correlation (C) of ARH GEF17-mCherry and LAP-Mps1 with 
or without reversine treatment of >40 cells (specific numbers indicated)/three independent experiments. (D) Coimmunoprecipitation of ARH GEF17 frag-
ments with Mps1: LAP-Mps1 and mCherry-tagged ARH GEF17 fragments (ΔNC-mCherry and ΔNC Y1216A-mCherry) were precipitated using GFP-binding 
protein coupled to agarose beads. Input and precipitates were analyzed by Western blot (anti-GFP and anti-mCherry). (E and F) FCCS of Mps1 and ARH 
GEF17 fragments. Exemplary cells (E) and normalized cross-correlation (F) of LAP-Mps1 and ARH GEF17 fragments (ΔNC-mCherry and ΔNC Y1216A-
mCherry) of >40 cells (specific numbers indicated)/three independent experiments. (G) In vitro pull-down of ARH GEF17 fragments with Mps1. His-tagged 
Mps1 (bait) and untagged ARH GEF17 fragments (ΔNC; target) were precipitated using His-tag binding protein coupled to Talon beads. Input, supernatants 
(Unbound), and precipitates (Bound) were analyzed by Western blot (anti–His-tag [middle] and anti-ARH GEF17 [bottom]). Coomassie brilliant blue staining 
was used as internal protein control in each condition. Boxes show median, 25–75%; whiskers show 1.5× interquartile range. **, P < 0.01 by two-tailed 
unpaired Student’s t test, compared with mEGFP and mCherry (C and F) or between metaphase and metaphase with reversine treatment (F). Slower migra-
tion of Mps1/ARH GEF17 bands could be caused by phosphorylation (A and D). Bars, 5 µm.
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ARH GEF17 depletion phenocopies Mps1 
inhibition
Given the strong checkpoint phenotype and loss of kinetochore 
protein localization, we reasoned that ARH GFEF17 could 
function in the regulation of SAC establishment or mainte-
nance. Two mitotic kinases, Aurora B and Mps1, are known 
to be involved in the recruitment of checkpoint components to 
kinetochores, which are essential to establish the SAC (Lan et 
al., 2004; Meraldi et al., 2004; Hewitt et al., 2010; Jelluma et 
al., 2010; Maldonado and Kapoor, 2011; Saurin et al., 2011). 
To test whether ARH GEF17 acts through Mps1 or Aurora B, 
we compared the mitotic phenotype of ARH GEF17-depleted 
cells with the phenotypes of cells in which either kinase was 
inhibited with increasing doses of the specific small molecule 
inhibitors reversine or hesperadin (Hauf et al., 2003; Santagu-
ida et al., 2010) by confocal time-lapse imaging and single-cell 
trajectory analysis with CellCognition (Fig. 3 A). Mps1 inhibi-
tion accelerated mitosis in a manner kinetically similar to ARH 
GEF17 depletion (Fig. 3 B), resulting in an indistinguishable 
mean early mitotic duration (Fig. 3 C). In contrast, Aurora B in-
hibition led to a very different phenotype of long prometaphase 
arrest followed by cytokinesis defects (Fig. 3, B and C). The 
two kinase inhibitors remained phenotypically distinct across 
different inhibitor concentrations. These results suggest that 
ARH GEF17 acts through Mps1 to ensure SAC activity.
ARH GEF17 and Mps1 interact 
during mitosis and Mps1 
phosphorylates ARH GEF17
If ARH GEF17 acts through Mps1 in SAC regulation, interac-
tion during mitosis is likely. To test this, we immunoprecipitated 
localization and affinity purification (LAP)–tagged Mps1 stably 
expressed from a BAC in HeLa cells that were also transfected 
with ARH GEF17-mCherry. Mps1 coimmunoprecipitated ARH 
GEF17 from mitotic cell extracts (Figs. 4 A and S3 A). To assay 
the interaction between Mps1 and ARH GEF17 in live mitotic 
cells, we performed fluorescence cross-correlation spectros-
copy (FCCS; Kohl et al., 2005; Maeder et al., 2007; Huet et 
al., 2010; Wachsmuth et al., 2015) in the same ARH GEF17- 
mCherry/LAP-Mps1 coexpressing cells used for immunopre-
cipitation, after arresting them in metaphase with the protea-
some inhibitor MG132 to prevent mitotic exit. When probing 
single-molecule cofluctuations of red fluorescent ARH GEF17 
with green fluorescent Mps1 (Fig. 4 B), we detected a signifi-
cant cross-correlation (12.4 ± 7.7%) between ARH GEF17 and 
Mps1, demonstrating that both proteins were moving as one 
particle in the cell, whereas the cross-correlation between the 
two fluorescent proteins alone was negligible at only 5.1 ± 5.5% 
(Fig. 4 C). The ARH GEF17–Mps1 interaction was specific to 
mitosis, as no significant cross-correlation (4.8 ± 5.5%) was ob-
served in interphase cells (Fig. S3 C).
Having demonstrated an interaction between the full-length 
proteins in mitotic cells, we repeated immunoprecipitation and 
FCCS with the central active domain (ΔNC) of ARH GEF17, 
which also interacted with Mps1, independently of its Rho-GEF 
activity (ΔNC Y1216A) and specifically in mitosis (Fig. 4, D–F; 
and Fig. S3, B and C). To test whether the interaction between 
ARH GEF17 and Mps1 is direct, we purified recombinant ARH 
GEF17-ΔNC and His-tagged Mps1 from Escherichia coli and 
performed in vitro pull-down assays. ARH GEF17-ΔNC was pre-
cipitated by His-Mps1 protein bound to beads (Figs. 4 G and S3 
D), but was not precipitated by His-tagged BubR1 (kinase domain) 
used as a negative control (Fig. S3 E). In summary, ARH GEF17 
binds to Mps1 in extracts and living cells in a mitosis-specific man-
ner, and the central domain (aa 667–1,306) is sufficient for this 
interaction and can interact directly with Mps1 in vitro.
Interestingly, we noticed that the Mps1 and ARH GEF17 
complex in live metaphase cells is significantly enhanced by 
acute reversine inhibition of Mps1 (Fig. 4, B and C; and Fig. 
S3 C). To examine whether ARH GEF17 is an Mps1 substrate, 
we performed in vitro phosphorylation assays with the recom-
binant proteins. Indeed, ARH GEF17-ΔNC was phosphorylated 
Figure 5. Mps1 phosphorylates ARH GEF17 in vitro. (A) In vitro kinase assay of Mps1 and ARH GEF17. Recombinant His-tag fused Mps1 (kinase) and 
untagged ARH GEF17-ΔNC or BSA (substrate) were incubated in the presence or absence of ATP. Total protein was visualized with Coomassie brilliant blue 
(CBB; left), and phosphorylated protein was visualized with Pro-Q Diamond (right). (B) Comparison of normalized mean intensity ratio between phosphor-
ylated protein and total protein in each condition. Quantification was performed from single experiment. (C) Potential phosphorylation sites of ARH GEF17 
by Mps1 identified by LC-MS/MS. Andromeda score, probability, and delta score are indicated for each site (see Materials and methods).
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by His-tagged Mps1 protein, whereas BSA, used as a negative 
control, was not a substrate (Fig.  5, A and B). Furthermore, 
using liquid chromatography-tandem mass spectrometry (LC-
MS/MS), we identified three threonines (T119, T312, and T375) 
in ARH GEF17 that were phosphorylated by Mps1 (Fig. 5 C). 
ARH GEF17 is therefore a substrate of Mps1 kinase.
ARH GEF17 is required for targeting of 
Mps1 to kinetochores
A kinase binding partner and substrate could be involved in 
targeting and/or activation of the kinase. To test whether ARH 
GEF17 is required for targeting of Mps1 to kinetochores, we 
investigated Mps1 localization in ARH GEF17-depleted cells by 
quantitative ratiometric immunofluorescence. Mps1 is normally 
localized both at kinetochores and in the cytoplasm in prometa-
phase cells. After depletion of ARH GEF17, Mps1 could no 
longer be detected at kinetochores, leading to a significantly 
reduced fluorescence ratio (Fig. 6 A), even though the overall 
protein expression level of Mps1 was not affected (Fig. S4 A). 
Furthermore, the expression of ARH GEF17-ΔNC rescued the 
kinetochore targeting of Mps1 (Fig. S4, B and C), indicating 
that the central domain is sufficient not only for binding Mps1 
but also for the targeting function of ARH GEF17.
To test whether loss of Mps1 accumulation affects its activity 
at kinetochores, we checked the phosphorylation of its kinetochore 
substrate KNL1 using a phospho-specific antibody (Yamagi-
shi et al., 2012). The significantly reduced immunofluorescence 
ratio showed that phosphorylation of KNL1 at kinetochores was 
diminished after ARH GEF17 depletion (Fig.  6  B). Therefore, 
ARH GEF17’s central domain is necessary for targeting Mps1 to 
kinetochores, which in turn is required for its activity toward kine-
tochore substrates. To conversely test if ARH GEF17 localization 
depends on the presence of Mps1, we knocked down Mps1 by 
RNAi and quantified ARH GEF17’s abundance on kinetochores. 
ARH GEF17 localization on kinetochores was significantly in-
creased in Mps1-depleted cells (Fig. S4 D), which had little re-
sidual Mps1 on their kinetochores (Fig. S4 E), although overall 
expression of ARH GEF17 did not increase (Fig. S4 A). Thus, ARH 
GEF17 can bind to kinetochores independently of Mps1.
Constitutive tethering of Mps1 to the 
kinetochore replaces ARH GEF17’s 
SAC function
If ARH GEF17’s main mitotic function is to target Mps1 to the 
kinetochore, constitutive tethering of Mps1 to kinetochores 
should make the SAC and mitosis independent of ARH GEF17. 
Figure 6. ARH GEF17 is required for targeting of Mps1 at kinetochores, and constitutive tethering of Mps1 to the kinetochore replaces ARH GEF17’s SAC 
function. (A and B, left) Exemplary prometaphase cells with LAP-Mps1 and phospho-KNL1 labeled at kinetochores. Overlay shows LAP-Mps1 (A) or ph-
KNL1 (Thr875; B; green) and CENP-A (red) after knockdown of ARH GEF17. (insets) High magnification of kinetochores. (right) Quantitative ratiometric 
comparison of LAP-Mps1 (A) or ph-KNL1 (B). Box plot comparing the mean intensity ratio between LAP-Mps1/CENP-A or ph-KNL1/CENP-A ratio of >600 
individual sister kinetochores/three independent experiments. Bars: (main) 5 µm; (insets) 0.5 µm. (C and D) Phenotypic rescue by artificial kinetochore 
tethering of Mps1 in the absence of ARH GEF17. (C) Mitotic events were automatically extracted after knockdown in cells stably expressing H2B-mCherry 
and mEGFP-CENP-B-Mps1 with or without 0.5 µM reversine treatment. Colors indicate H2B-mCherry morphology classes. (D) Comparison of early mitotic 
duration. Box plot comparing the duration of prometaphase and metaphase in each condition. Mean and standard deviation of >120 mitotic events 
(n indicated for each condition)/three independent experiments. Boxes show median, 25–75%; whiskers show 1.5× interquartile range. **, P < 0.01 by 
two-tailed unpaired Student’s t test, compared with si(Scrambled) (A and B), si(Scrambled) versus si(ARH GEF17); si(hARH GEF17) versus mEGFP-CENP-B-
Mps1 expression with or without reversine (D). Sc, Scrambled; KD, knockdown.
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To test this, we fused Mps1 to CENP-B, which constitutively 
localizes at kinetochores/centromeres, and checked whether the 
mitotic defects caused by ARH GEF17 depletion were rescued. 
In HeLa cells stably expressing CENP-B–Mps1 (at a level sim-
ilar to that of endogenous Mps1; Fig. S5 A), the fusion protein 
localized to kinetochores throughout mitosis (Fig. S5 B), in 
contrast to Mps1’s normally only transient kinetochore localiza-
tion in prometaphase. Except for a minor delay, the presence of 
CENP-B–Mps1 had little effect on the division kinetics of HeLa 
cells (Fig. S5, C and D), which maintained normal metaphase 
duration, chromosome alignment, and segregation despite ARH 
GEF17 depletion (Fig. 6, C and D), indicative of normal SAC 
activity. This phenotypic rescue of ARH GEF17 knockdown 
by kinetochore tethering of Mps1 was dependent on its kinase 
activity, as it was abolished by reversine inhibition (Fig. 6, C 
and D) in a dose-dependent manner (Fig. S5 E). These data 
demonstrate that Mps1 acts downstream of ARH GEF17, whose 
essential mitotic function is therefore most likely the targeting 
of the kinase to the kinetochore.
ARH GEF17-Mps1 interaction is regulated 
by Mps1 activity
Our data so far favor a model in which Mps1 can be targeted 
to kinetochores only after binding to ARH GEF17. This com-
plex is likely to be regulated to achieve the right concentra-
tion and activity of the kinase at the kinetochore. Because we 
showed that ARH GEF17 is a substrate of Mps1 (Fig. 5) and 
that the Mps1/ARH GEF17 interaction in the cytoplasm of live 
mitotic cells is enhanced upon reversine inhibition (Fig.  4, 
C and D), we then asked whether Mps1 activity regulates its 
own interaction with ARH GEF17 also at kinetochores. We 
first addressed this by examining whether the kinetochore 
Figure 7. ARH GEF17–Mps1 interaction is regulated by Mps1 activity. (A and B, left) ARH GEF17 (ARH GEF17-mCherry; A) or Mps1 (LAP-Mps1; B) localiza-
tion at kinetochores in prometaphase with 0.5 µM reversine (Rev; 2 h before fixation). (insets) High magnification of kinetochores. (right) Quantitative com-
parison of ARH GEF17-mCherry/ACA and LAP-Mps1/ACA ratios on >260 individual sister kinetochores/three independent experiments. (C and D) FRAP 
of Mps1 (LAP-Mps1; C) and ARH GEF17 (ARH GEF17-mCherry; D) at kinetochores in nocodazole (Noco)-treated mitotic cells with or without reversine treat-
ment. The kinetochore region of the cell was bleached (white circles) and imaged every 0.4 s for 40 s (100 frames). (bottom) High magnification of kineto-
chores. FRAP curves were normalized between 1 (prebleach value) and 0 (postbleach value) and plotted over time. Boxes show median, 25–75%; whiskers 
show 1.5× interquartile range. **, P < 0.01 by two-tailed unpaired Student’s t test compared with si(Scrambled). Bars: (A–D) 5; (A and B, insets) 1 µm.
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localization of Mps1 and ARH GEF17 was affected by re-
versine inhibition of the kinase. Indeed the localization of 
both interaction partners at kinetochores was significantly in-
creased after reversine addition to MG132 metaphase-arrested 
cells (Fig.  7, A and B). Furthermore, FRAP assays in noco-
dazole-arrested prometaphase cells showed that both ARH 
GEF17 and Mps1 bind to kinetochores in a dynamic fash-
ion, with half-times of a few seconds, and that the recovery 
of both proteins was significantly slowed down by reversine 
treatment (Fig.  7, C and D), whereas the recovery of Bub1 
used as a control kinetochore protein was unaffected (Fig. S5 
F). Collectively, these data show that kinetochore-localized 
ARH GEF17/Mps1 are in dynamic exchange with their cyto-
plasmic pool and that Mps1 activity limits its interaction with 
ARH GEF17 also on kinetochores.
Discussion
Model: The ARH GEF17–Mps1 complex 
acts as a molecular timer of Mps1 activity 
at the kinetochore
The molecular mechanism and regulation of the SAC are sub-
jects of intense study. Previous studies had already shown that 
Mps1 plays a key role; however, how Mps1 itself is regulated 
is poorly understood. In this study, we characterized a newly 
identified essential SAC regulator, ARH GEF17. Our data 
demonstrate that ARH GEF17 is a binding partner and substrate 
of Mps1. This interaction is essential to target Mps1 kinase ac-
tivity to kinetochores, which is critical for integrity of the outer 
kinetochore and the assembly and function of checkpoint com-
plexes. Collectively, this provides the mechanistic explanation 
for ARH GEF17’s novel mitotic phenotype, which is indepen-
dent from its interphase function as a RhoGEF in regulation 
of the actin cytoskeleton. It has been reported that Ndc80 and 
Aurora B are needed for Mps1 localization to the kinetochores 
(Martin-Lluesma et al., 2002; Santaguida et al., 2011; Martin- 
Lluesma et al., 2002; Saurin et al., 2011; Santaguida et al., 
2011; Nijenhuis et al., 2013; Zhu et al., 2013; Hiruma et al., 
2015). Our data show that kinetochore localization of neither 
Ndc80 nor Aurora B is affected by ARH GEF17 depletion, argu-
ing that ARH GEF17 acts directly on Mps1.
The observation that the Mps1–ARH GEF17 interaction, 
their kinetochore targeting, and their residence time at the kine-
tochore are counteracted by Mps1’s activity led us to propose a 
model in which the Mps1–ARH GEF17 complex would act as 
a molecular timer of a diffusion reaction–targeting mechanism 
that ensures the right amount of this key mitotic kinase at kine-
tochores (Fig. 8). In this model, ARH GEF17 forms a complex 
with Mps1 in the cytoplasm. This complex can then bind to 
the kinetochore and allows Mps1 to phosphorylate local target 
substrates. Because Mps1 also phosphorylates ARH GEF17, the 
Mps1–ARH GEF17 complex is short lived and promotes its own 
dissociation, which in turn releases Mps1 and ARH GEF17 from 
the kinetochore. The dissociated proteins are then available to 
form new Mps1–ARH GEF17 complexes, presumably after 
dephosphorylation of ARH GEF17 by a counteracting phos-
phatase. It will be very interesting to further dissect the interde-
pendence of ARH GEF17 and Mps1 function with kinase-dead 
Mps1–expressing cell lines in future experiments.
Although we do not have direct evidence, it is tempting to 
speculate that ARH GEF17 binding does not just confer kineto-
chore targeting to Mps1, but also activates its enzyme activity. 
That ARH GEF17 can localize to kinetochores even if Mps1 is 
knocked down suggests that Mps1 may bind ARH GEF17 both 
in cytoplasm and at the kinetochore. The fact that kinetochore- 
localized ARH GEF17 and Mps1 exchanged dynamically with 
the cytoplasm and resided longer at kinetochores when Mps1 
was inhibited is consistent with the idea that the ARH GEF17–
Mps1 complex may dissociate from the kinetochore as a unit; 
however, we cannot formally rule out that ARH GEF17 and 
Mps1 dissociate from kinetochores independently. The molec-
ular timer mechanism we propose here, however, would work 
very similarly in either scenario. Such a molecular timer mech-
anism would be conceptually similar to the regulatory mecha-
nism of GTPases or the ones proposed for the APC/C inhibitor 
Emi1 or cytosolic Mad2/Bub1 complex (Reimann et al., 2001; 
Maldonado and Kapoor, 2011).
Materials and methods
BAC cloning
Mouse ARH GEF17 BAC clone RP23-452C8 was obtained from 
BAC PAC Resources. Subsequent cloning steps were performed as 
previously described (Poser et al., 2008). Primers for addition of 
the LAP tag at the C terminus were designed using the MitoCheck 
BACfinder resources website (http ://www .mitocheck .org /cgi -bin 
/BACfinder): 5′-AGA CCG TGG GCC GAG ATG ACA GCA CAA ACC 
ACC TAC TCC TGT GGA GGG TGG ATT ATG ATA TTC CAA CTA CTG-
3′ and 5′-GAA GAA CTG CTC AAG AAG ACT CGG ACG GGA GAC 
ACC GGG TCC TGA GTG GAC AGG TGG ACG GGA GTC GGA CG-3′.
Figure 8. Model for the recruitment of ARH GEF17 and 
Mps1 at kinetochores in early mitosis. ARH GEF17 forms a 
complex with Mps1 in the cytoplasm, which binds to the kine-
tochore (KT) and allows Mps1 to phosphorylate local target 
substrates. Because Mps1 also phosphorylates ARH GEF17, 
the Mps1–ARH GEF17 complex is short lived and promotes 
its own dissociation, which in turn releases Mps1 and ARH 
GEF17 from the kinetochore. The dissociated proteins are 
then available to form new Mps1–ARH GEF17 complexes, 
presumably after dephosphorylation of ARH GEF17 by a 
counteracting phosphatase.
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Cell lines
HeLa Kyoto cells were grown in DMEM containing 10% FBS, 2 mM 
glutamine, 1 mM sodium pyruvate, and 100 µg/ml penicillin and strepto-
mycin. H2B-mCherry HeLa Kyoto cells were described previously (Neu-
mann et al., 2010). The HeLa Kyoto cell line expressing H2B-mCherry 
and EGFP-LaminA was provided by the Mattaj Laboratory (European 
Molecular Biology Laboratory, Heidelberg, Germany). The HeLa 
Kyoto cell lines expressing LAP-tagged mSpc24 BAC/H2B-mCherry, 
LAP-tagged mZW10 BAC/H2B-mCherry, LAP-tagged hBub1, and 
LAP-tagged mMad2 BAC were provided by A.A. Hyman (Max Planck 
Institute of Molecular Cell Biology and Genetics, Dresden, Germany). 
H2B-mCherry was transfected into HeLa cells expressing LAP-tagged 
mMad2 BAC with Fugene6 (Promega) according to the manufacturer’s 
instructions. A clone stably expressing H2B-mCherry was isolated by 
selection with 0.5 µg/ml puromycin (Calbiochem). LAP-tagged mouse 
ARH GEF17 BAC was transfected into HeLa cells expressing H2B-
mCherry with Lipofectamine 2000 (Invitrogen) according to the man-
ufacturer’s instructions. A clone stably expressing LAP-tagged mARH 
GEF17 BAC was isolated by selection with 500 µg/ml Geneticin (Invitro-
gen). The HeLa Kyoto cell line expressing LAP-tagged hMps1 BAC was 
provided by A. Mussachio (Max Planck Institute of Molecular Biology, 
Dortmund, Germany). The ARH GEF17 fragment (ARH GEF17 [667–
2,063]-mEGFP: ΔN, ARH GEF17 [667–1,306]-mEGFP: ΔNC, ARH 
GEF17 [667–1,306]–Y1216A-mEGFP: ΔNC Y2116A, ARH GEF17 
[1–582]-mEGFP: ΔC-siRa [mutations: C1502T, A1508C, and G1511A], 
ARH GEF17 [109–664]-mEGFP: ΔC-siRb [mutations: C1508C, 
G1511A, T1514C, and G1517A], ARH GEF17 [1,304–2,063]-mEGFP: 
ΔN1, or mEGFP-ARH GEF17 [1,304–2,063]: ΔN2) or mEGFP-CEN 
PB-Mps1 was transfected into HeLa cells expressing H2B-mCherry 
with Fugene6 (Promega) according to the manufacturer’s instructions. 
A clone stably expressing each ARH GEF17 fragment or mEGFP-CEN 
PB-Mps1 was isolated by selection with 500 µg/ml Geneticin.
RNA interference
siRNAs (Ambion) are listed in Table S1.
For quantitative phenotypic time-lapse imaging, cells were 
seeded on ready-to-transfect 8-well LabTEK slides (Thermo Fisher 
Scientific) as described previously (Erfle et al., 2008; Neumann et al., 
2010). For quantitative immunofluorescence, siRNA was transfected 
using Lipofectamine 2000.
High-resolution time-lapse microscopy imaging
Images were acquired with the LAS AF and Matrix Screen Application 
software on an SP5 confocal microscope with a 63× PlanApochromat 
oil objective, NA 1.4 (Leica). Live-cell imaging was performed at 37°C 
using CO2-independent medium without phenol red (Custom StemSpan 
SFEM by Stem Cell) containing 20% FBS, 2 mM l-glutamine, and 100 
mg/ml penicillin and streptomycin. Images were acquired every 3 min.
Automatic quantitative phenotypic time-lapse imaging and analysis
To quantify the occurrence of the mitotic phenotypes, images were ac-
quired with CellR software on an automated ScanR epifluorescence 
microscope (Olympus) with Plan 10×, NA 0.4 air objective (Olympus), 
and analyzed as described previously (Held et al., 2010; Neumann et 
al., 2010; Walter et al., 2010). To quantify the duration of prometa-
phase and metaphase, images were acquired with ZEN 2010 software 
on a confocal microscope (LSM 780; ZEI SS) with a 63× PlanApochro-
mat oil objective, NA 1.4 (ZEI SS). Live-cell imaging was performed 
at 37°C using CO2-independent medium without phenol red (Custom 
StemSpan SFEM) containing 20% FBS, 2 mM l-glutamine, and 100 
mg/ml penicillin and streptomycin. Automated quantitative analysis of 
dividing H2B-mCherry–expressing cells was used to monitor mitotic 
progression in single cells. For this, nuclei were detected in the H2B-
mCherry channel and classified as previously described (Held et al., 
2010; Walter et al., 2010). For classification of nuclei in images acquired 
every 5 min (Figs. 6 and S5), we defined nine morphological classes: 
interphase, prophase, prometaphase, metaphase, early anaphase, late 
anaphase, telophase, cell death, and polylobed nuclei. For experiments 
with image acquisition every 3 min (Fig. 3), the prophase class was split 
into two classes corresponding to early and late prophase. The training 
set contained ∼1,000 manually labeled nuclei, which were detected 
with an overall accuracy of >90.0% in 10-fold cross-validation. Cells 
were tracked with a constrained nearest-neighbor tracking procedure, 
and mitotic onset was detected as interphase–prophase or interphase–
prometaphase transition. To reduce the effect of classification errors 
on phase length measurements, classification results were corrected 
with hidden Markov models (Held et al., 2010; Walter et al., 2010). 
To inhibit the Rho activity of hARH GEF17, CT04 (Cytoskeleton) was 
treated before imaging, and cells were then imaged for 24 h (Fig. 2 E).
Immunofluorescence
All steps were performed at RT. Cells were fixed with 3.7% parafor-
maldehyde in PHEM buffer (45 mM Pipes, 45 mM HEP ES, 10 mM 
EGTA, 5 mM MgCl2, and 1 mM PMSF, pH 6.8) for 10 min and per-
meabilized for 10 min with 0.2% Triton X-100 in PHEM buffer. Cells 
were blocked with 2% BSA in PHEM buffer for 1 h. Samples were 
incubated with primary antibodies in 2% BSA in PHEM buffer for 
2 h, washed, and incubated with secondary antibodies for 60 min in 
2% BSA in PHEM. After washing, they were imaged in PHEM buffer 
with ZEN 2010 software on a confocal microscope with a 63× Pla-
nApochromat oil-objective, NA 1.4 (ZEI SS). The following antibodies 
were used: anti-hARH GEF17 (rabbit; Abcam) 1:100 and anti-CRE ST 
(anti-centromere antibody [ACA], human; Europe Bioproducts) 1:500. 
Secondary antibodies were anti–rabbit Alexa Fluor 488 (Molecular 
Probes) 1:500 and anti–human Alexa Fluor 647 (Molecular Probes) 
1:500. DNA was stained with Hoechst 33342 (Sigma-Aldrich). To 
retrieve the antigen of hARH GEF17 in HeLa Kyoto cells, cells were 
incubated with 1% SDS (SER VA) for 5 min after cells were fixed with 
3.7% paraformaldehyde in PHEM buffer (Fig. S2 E).
Quantitative immunofluorescence at kinetochore
Immunofluorescence and imaging were performed as described earlier. 
The following antibodies were used: anti-GFP (rabbit, MBL) 1:500, 
anti-CEN PA (mouse, 3-19; MBL) 1:100, anti-Mad2 (mouse, COV 
ANCE) 1:100, anti-Bub1 (mouse, 14H5; Millipore) 1:100, anti-BubR1 
(mouse, 8G1; MBL) 1:100, anti-CRE ST (ACA, human) 1:500, anti-
BLI NKIN, and anti-ZW10 (mouse, gift from J.  Swedlow, Dundee 
University, Dundee, Scotland, UK) 1:50, and anti–ph-KNL1 (Thr875; 
rabbit; gift from Y.  Watanabe, Tokyo University, Tokyo, Japan; 
Yamagishi et al., 2012) 1:2,000. Secondary antibodies were anti–mouse 
Alexa Fluor 488 (Molecular Probes) 1:500, anti–rabbit Alexa Fluor 488 
(Molecular Probes) 1:500, anti–mouse Alexa Fluor 546 (Molecular 
Probes) 1:500, and anti–human Alexa Fluor 647 (Molecular Probes) 
1:1,000. To measure target protein expression levels at kinetochores/
centromeres in 3D images, segmentation of the mCherry or Hoechst 
33342 channel was used to create a chromosome mask within which 
anti–CENP-A spots were detected where the mean intensities of 
anti–CENP-A or ACA marker protein were measured. To correct 
for variability in the intensity of the target kinetochore proteins, we 
normalized the target signal to the kinetochore signal of the CENP-A 
antibody or ACA antibody. Segmentation and intensity measurements 
were performed automatically by an routine developed in-house and 
implemented in Fiji (https ://github .com /cmci /3D -DotDetection; 
Sbalzarini and Koumoutsakos, 2005; Schindelin et al., 2012).
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Mitotic chromosome spreads
HeLa Kyoto cells were cultured for 21 h in the presence of 0.33 µM noco-
dazole (Sigma-Aldrich). Cells arrested in mitosis were then harvested 
by shake-off, treated with a hypotonic buffer (16.6% FBS in sterilized 
water) for 5 min at 37°C, and attached to micro–cover glass (Deckgla-
ser; Carolina Biologicals) with a Cytospin 4 Centrifuge (Thermo Fisher 
Scientific). The cells on the glass slide were fixed with the paraformal-
dehyde solution described earlier, followed by immunofluorescence.
Western blotting
Cells were resuspended in ice-cold lysis buffer (10  mM Tris-Cl, pH 
7.5, 150 mM NaCl, 0.1% SDS, 5 mM EDTA, and 1% Triton X-100) 
supplemented with complete protease inhibitor cocktail and PhosSTOP 
phosphatase inhibitor cocktail (Roche). After 30-min incubation on ice, 
cells were centrifuged and the supernatants were collected. Cell lysates 
were loaded into NuPAGE 4–12% Bis-Tris Mini Gels (Life Technolo-
gies) and transferred to PVDF membranes (Millipore). The following 
antibodies were used for Western blotting: anti-ARH GEF17 (rabbit, 
ab67278; Abcam) 1:1,000, anti-GFP (mouse, 7.1/3.1; Boehringer 
Mannheim; and rabbit; MBL) 1:1,000, anti-Aurora B (mouse, 6; BD 
Transduction; and rabbit; Abcam) 1:1,000, anti-GAP DH (mouse, 6C5; 
Santa Cruz Biotechnology) 1:2,000, anti-Mad2 (mouse; COV ANCE) 
1:500, anti-Bub1 (mouse, 14H5; Millipore) 1:1,000, anti-BubR1 
(mouse, 8G1; MBL) 1:1,000, anti-Mps1 (sheep, gift from S.S.  Tay-
lor, Manchester University, Manchester, England, UK; Tighe et al., 
2008) 1:2,000, anti-DsRed/mCherry (rabbit; Clontech) 1:1,000, and 
anti-His (mouse; Qiagen) 1:2,000. Secondary antibodies were anti–
mouse Alexa Fluor 680 (Molecular Probes) 1:15,000, anti–rabbit Alexa 
Fluor 680 (Molecular probes) 1:15,000, anti-mouse IRDye800CW 
(LI-COR Biosciences) 1:10,000, anti-rabbit IRDye800CW (LI-COR 
Biosciences) 1:10,000, anti-sheep IRDye800CW (LI-COR Biosci-
ences) 1:10,000, HRP-conjugated anti-mouse (Promega) 1:5,000, and 
HRP-conjugated anti-rabbit (Promega) 1:5,000. Blots were scanned 
using the Odyssey imaging device (LI-COR Biosciences) or detected 
with ECL (GE Healthcare).
Immunoprecipitation
Cells were resuspended in ice-cold lysis buffer (10 mM Tris-Cl, pH 7.5, 
150 mM NaCl, 0.1% SDS, 1% Triton X-100, 1% deoxycholate, and 
5 mM EDTA, supplemented with complete protease inhibitor cocktail, 
PhosSTOP phosphatase inhibitor cocktail [Roche], Benzonase [Sig-
ma-Aldrich], and 1 mM PMSF). After incubation for 30 min on ice, 
cells were centrifuged, and the supernatants were collected. Agarose 
beads coupled to GFP-binding protein (GFP-Trap_A; Chromotek) 
were prewashed, added to the supernatants, and incubated for 1 h at 
4°C.  The beads were then washed three times with lysis buffer and 
resuspended in SDS-PAGE sample buffer.
FCCS
Measurements and analysis were performed as previously described 
(Wachsmuth et al., 2015), using a ConfoCor3 system (LSM 780; ZEI 
SS). In brief, light was focused by a water immersion 40× 1.2-NA ob-
jective and collected by two avalanche photodiodes in the spectrally 
distinct regions 505–540 nm (Fg) and 600–650 nm (Fr) after pass-
ing through a pinhole set to 1 Airy unit. Samples were incubated at 
37°C and excited with 488- and 561-nm lasers, using minimal power 
(<1 kW · cm–2) to reduce photobleaching, photophysical effects, and 
cellular toxicity. The instrument was calibrated using Alexa Fluor 488 
and 568 to align the pinholes, perform cover glass corrections, and de-
termine the size and geometry of the focal volume before each experi-
ment. Each measurement was taken for 45 s in total, with cells selected 
manually based on relatively low expression levels below an arbitrary 
threshold count rate of 1,000 kHz. For measurements of transiently 
transfected ARH GEF17-mCherry and EGFP-MPS1 stably expressed 
from a BAC, count rates in the mCherry channel were consistently 
higher relative to the GFP channel, as were counts per molecule (mean 
count rate/particle number), therefore minimizing spectral cross-talk 
(Bacia et al., 2012). Cross-talk was quantified using mEGFP expressed 
alone, and an EGFP-MBP-mCherry fusion protein was used as a posi-
tive control of the maximum measurable cross-correlation in our setup. 
Measurements in transfected control cells were taken 24 h after trans-
fection. For experiments including reversine, 0.5  µM reversine was 
added 0.5 h before imaging to cells synchronized in metaphase by prior 
treatment with 20 µM MG132.
Data analysis was performed in Fluctuation Analyzer software as 
previously described (Wachsmuth et al., 2015). Calculation of photo-
bleaching-corrected correlation functions was followed by corrections 
for photobleaching, background, spectral cross-talk, nonperfect overlap 
of the observation volumes, and fluorophore maturation (Boeke et al., 
2014) and complemented by fitting the data with model functions for 3D 
normal/anomalous diffusion, resulting in normalized cross-correlation 
amplitudes between ∼0 for the negative and ∼0.5 for the positive control.
FRAP
FRAP experiments were performed on a confocal microscope with a 
water immersion 40× NA 1.2 objective. HeLa Kyoto cells stably ex-
pressing Mps1 fused with LAP, ARH GEF17 fused with mCherry, or 
Bub1 fused with LAP were imaged. Five prebleach images were ac-
quired before bleaching. The signal at the kinetochore in nocodazole 
mitotic-arrested cells was then photobleached in nine iterations with 
full intensity of the 488- or 561-nm lasers. Fluorescence recovery was 
followed every 0.4 s for a total time of 40 s. Intensity values were nor-
malized between 1 (prebleach) and 0 (postbleach) after subtraction of 
acquisition bleaching and background. The t1/2 value was defined as the 
half-maximal recovery time of the mobile fraction of each condition.
Purification of ARH GEF17 recombinant protein
The human ARH GEF17 fragment (aa 667–1,306; ΔNC) was cloned 
into a pFastBac-HT vector (pFastBac-HT-ΔNC; Invitrogen) and ex-
pressed using the baculovirus protein expression system. Pellets from 
1 liter of infected Sf21 cells were resuspended in buffer (50 mM Tris-
HCl, pH 7.5, 500 mM NaCl, 5 mM MgCl2, 250 mM sucrose, 1 mM 
DTT, 10 mM imidazole, SmDNase, and complete protease inhibitor), 
lysed by sonication, and centrifuged for 30 min at 4°C, 30,000 g. The 
supernatant was collected and incubated with 2  ml NiNTA Agarose 
resin for 30 min at RT. Beads were collected and washed with buffer, 
and the protein was eluted with elution buffer (50 mM Tris-HCl, pH 
7.5, 500 mM NaCl, 5 mM MgCl2, 250 mM sucrose, 1 mM DTT, and 
250  mM imidazole). The eluted fractions were pooled and dialyzed 
into ion exchange chromatography (IEX) running buffer (50 mM Tris-
HCl, pH 7.5, 50 mM NaCl, and 1 mM DTT) overnight at 4°C, purified 
using a HiTrapQ column, and eluted with a gradient IEX elution buffer 
(50 mM Tris-HCl, pH 7.5, 1 M NaCl, and 1 mM DTT). Eluted fractions 
were then dialyzed into 25 mM Tris, pH 7.6, 150 mM NaCl, 1 mM 
TCEP, 0.2% Triton X-100, and 5% glycerol and concentrated.
For the kinase assay and mass spectroscopy, part of the pooled 
and eluted fractions after the initial NiNTA purification were dialyzed 
into phosphatase buffer (50 mM Hepes, pH 7.5, 50 mM NaCl, 2 mM 
DTT, and 0.01% Brij35) and treated with Lambda phosphatase (New 
England Biolabs, Inc.) for 1 h at 30°C. The sample was adjusted to 
250 mM NaCl and 10 mM imidazole and incubated with NiNTA as 
described earlier to remove the phosphatase. It was then further purified 
by IEX as described earlier. The His-tag was optionally removed by 
incubation with TEV protease for further experiments.
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In vitro pull-down assay
Pull-downs were performed with 1 µg of each recombinant protein in 
an equilibration buffer containing 25 mM Tris-HCl, pH 7.6, 150 mM 
NaCl, 5% glycerol, and 0.1% Triton X-100. Either His-tagged Mps1 
alone or His-tagged BubR1 (kinase domain) was used as affinity bait 
on the TAL ON Metal Affinity Resin (Clontech) for 1  h at 4°C.  The 
washed beads were then incubated with nontagged ARH GEF17 (aa 
667–1,306) for 1 h at 4°C. After washing with the equilibration buffer, 
the beads were analyzed for protein content by SDS-PAGE. His-tagged 
Mps1 and BubR1 recombinant protein were provided by A. Mussachio.
In vitro kinase assay
200 nM of Mps1 and ARH GEF17 or BSA with 200 nM of each 
were incubated with kinase buffer containing 12.5  mM Tris-Cl, 
pH 7.5, 35 mM KCl, 1 mM MgCl2, 50 µM EGTA, 100 µM DTT, and 1× 
phosStop (Roche) at 30°C for 3 h in the absence or presence of ATP/Mg 
cocktail (0.25 mM ATP; Merck). The reaction was stopped with 20 mM 
EDTA. The samples were separated by SDS-PAGE gel and stained 
with colloidal Coomassie (Sigma-Aldrich), or they were blotted and 
the phosphorylated protein was visualized with Pro-Q Diamond (Life 
Technologies) and visualized using the Typhoon imaging device (Fuji).
LC-MS/MS
Samples were separated by SDS-PAGE and stained with Coomassie. 
The bands were cut from the gel digested with trypsin, and the peptides 
were extracted. Peptides were separated using the Waters nanoAcquity 
UPLC system. After the peptides were trapped with the column, the 
outlet of the analytical column was coupled directly to the mass spec-
trometer (Orbitrap Velos Pro; Thermo Fisher Scientific). The most in-
tense ions (up to intensity 15) from the full-scan MS were selected for 
sequencing. After processing the data using MSConvert (ProteoWizard, 
v.2.0) and Mascot (v2.2.07), with which the data were searched against 
a Uniprot human database with a list of common contaminants ap-
pended, to ascertain the protein identifications of the gel bands, the data 
were searched with MaxQuant (v1.2.2.5) against a database containing 
the sequences of the identified proteins. The data were searched with 
the following modifications: carbamidomethyl (C; fixed) AND phos-
pho (STY) AND oxidation (M; variable). Only phosphopeptides with 
Andromeda score >60 were reported, and only the phosphorylation 
sites with a probability score higher than 0.75 and a score difference 
(delta score) higher than 5 were considered (Marchini et al., 2011).
Online supplemental material
Table S1 shows the list of siRNAs. Fig. S1 shows knockdown 
efficiency and rescue validation for ARH GEF17. Fig. S2 demonstrates 
specificity of ARH GEF17 knockdown, endogenous ARH GEF17 
localization, effect on additional kinetochore protein targeting by ARH 
GEF17 knockdown, and ARH GEF17 fragment rescue controls. Fig. 
S3 shows that ARH GEF17 and Mps1 interact during mitosis. Fig. S4 
demonstrates that ARH GEF17 is essential for kinetochore targeting of 
Mps1. Fig. S5 shows that constitutive localization of Mps1 rescued the 
effect of ARH GEF17 knockdown during mitosis and FRAP data of a 
control kinetochore protein. Online supplemental material is available 
at http ://www .jcb .org /cgi /content /full /jcb .201408089 /DC1.
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